[1]Patent:WO2009/43890,2009,A1.Locationinpatent:Page/Pagecolumn53
[2]EuropeanJournalofMedicinalChemistry,2019,vol.164,p.92-105
[3]BioorganicChemistry,2020,vol.100
[4]BioorganicandMedicinalChemistryLetters,2013,vol.23,p.5936-5940
[5]JournalofHeterocyclicChemistry,1980,vol.17,p.819-821
[6]BioorganicandMedicinalChemistry,2000,vol.8,p.601-615
[7]JournalofMedicinalChemistry,2012,vol.55,p.68-83
[8]OrganicProcessResearchandDevelopment,2012,vol.16,p.1717-1726
[9]ChemMedChem,2019,vol.14,p.1257-1270
[1]Patent:WO2005/19184,2005,A1.Locationinpatent:Page/Pagecolumn29
[2]Patent:WO2014/141065,2014,A1.Locationinpatent:Page/Pagecolumn46;47
[3]OrganicandBiomolecularChemistry,2014,vol.12,p.8036-8047
[4]Patent:WO2018/81167,2018,A1.Locationinpatent:Page/Pagecolumn107;108
[5]JournalofMedicinalChemistry,2022,vol.65,p.5449-5461
[1]CurrentPatentAssignee:NOVONORDISKA/S-WO2005/19184,2005,A1Locationinpatent:Page/Pagecolumn29
[1]TetrahedronLetters,2016,vol.57,p.2898-2900
[1]TetrahedronLetters,2016,vol.57,p.2898-2900
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101